QQQ   354.74 (+0.78%)
AAPL   180.40 (+0.17%)
MSFT   334.43 (+0.56%)
META   274.04 (+0.52%)
GOOGL   124.88 (+0.94%)
AMZN   124.75 (+1.61%)
TSLA   215.95 (+4.06%)
NVDA   393.47 (-1.06%)
NIO   7.70 (+2.12%)
BABA   84.98 (+2.39%)
AMD   118.38 (-0.91%)
T   15.10 (-4.49%)
F   12.44 (+2.73%)
MU   68.93 (-0.23%)
CGC   0.84 (+0.74%)
GE   106.53 (+1.78%)
DIS   91.07 (+2.80%)
AMC   4.55 (+0.00%)
PFE   38.50 (+1.26%)
PYPL   64.07 (+1.62%)
NFLX   404.34 (+0.30%)
QQQ   354.74 (+0.78%)
AAPL   180.40 (+0.17%)
MSFT   334.43 (+0.56%)
META   274.04 (+0.52%)
GOOGL   124.88 (+0.94%)
AMZN   124.75 (+1.61%)
TSLA   215.95 (+4.06%)
NVDA   393.47 (-1.06%)
NIO   7.70 (+2.12%)
BABA   84.98 (+2.39%)
AMD   118.38 (-0.91%)
T   15.10 (-4.49%)
F   12.44 (+2.73%)
MU   68.93 (-0.23%)
CGC   0.84 (+0.74%)
GE   106.53 (+1.78%)
DIS   91.07 (+2.80%)
AMC   4.55 (+0.00%)
PFE   38.50 (+1.26%)
PYPL   64.07 (+1.62%)
NFLX   404.34 (+0.30%)
QQQ   354.74 (+0.78%)
AAPL   180.40 (+0.17%)
MSFT   334.43 (+0.56%)
META   274.04 (+0.52%)
GOOGL   124.88 (+0.94%)
AMZN   124.75 (+1.61%)
TSLA   215.95 (+4.06%)
NVDA   393.47 (-1.06%)
NIO   7.70 (+2.12%)
BABA   84.98 (+2.39%)
AMD   118.38 (-0.91%)
T   15.10 (-4.49%)
F   12.44 (+2.73%)
MU   68.93 (-0.23%)
CGC   0.84 (+0.74%)
GE   106.53 (+1.78%)
DIS   91.07 (+2.80%)
AMC   4.55 (+0.00%)
PFE   38.50 (+1.26%)
PYPL   64.07 (+1.62%)
NFLX   404.34 (+0.30%)
QQQ   354.74 (+0.78%)
AAPL   180.40 (+0.17%)
MSFT   334.43 (+0.56%)
META   274.04 (+0.52%)
GOOGL   124.88 (+0.94%)
AMZN   124.75 (+1.61%)
TSLA   215.95 (+4.06%)
NVDA   393.47 (-1.06%)
NIO   7.70 (+2.12%)
BABA   84.98 (+2.39%)
AMD   118.38 (-0.91%)
T   15.10 (-4.49%)
F   12.44 (+2.73%)
MU   68.93 (-0.23%)
CGC   0.84 (+0.74%)
GE   106.53 (+1.78%)
DIS   91.07 (+2.80%)
AMC   4.55 (+0.00%)
PFE   38.50 (+1.26%)
PYPL   64.07 (+1.62%)
NFLX   404.34 (+0.30%)
OTCMKTS:CBIS

Cannabis Science (CBIS) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.0050
$0.0050
50-Day Range
$0.0050
$0.0050
52-Week Range
$0.00
$0.06
Volume
N/A
Average Volume
4.85 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CBIS stock logo

About Cannabis Science (OTCMKTS:CBIS) Stock

Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, benefits of medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug; and a research collaboration agreement with Dana-Farber Cancer Institute, Inc. to develop and investigate the use of cannabinoids to cure various cancers, as well as with Stellenbosch University to treat chronic pelvic pain associated with pelvic inflammatory disease in women, chronic prostatitis in men, and other chronic pain associated with other indications. The company was formerly known as Gulf Onshore, Inc. and changed its name to Cannabis Science, Inc. in April 2009. The company was incorporated in 1996 and is based in Irvine, California. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.

Receive CBIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Science and its competitors with MarketBeat's FREE daily newsletter.

CBIS Stock News Headlines

The Real Problem With "Made in America" Lithium
Politicians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple.
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
KWC to host medical cannabis forum
See More Headlines


CBIS Company Calendar

Last Earnings
7/28/2015
Today
6/02/2023

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Cannabis
Sector
Medical
Current Symbol
OTCMKTS:CBIS
CUSIP
137648101
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Raymond C. Dabney (Age 54)
    Co-Founder, Chairman, CEO & Pres
  • Mr. Benjamin C. K. Tam (Age 67)
    CFO, Sec. & Director
  • Mr. Robert James KaneMr. Robert James Kane (Age 43)
    COO & Director
  • Mr. Mario Lap (Age 67)
    Pres of European Operations & Director
  • Mr. Bret Bogue
    Director of Horticulture and Head of R&D













CBIS Stock - Frequently Asked Questions

How were Cannabis Science's earnings last quarter?

Cannabis Science Inc (OTCMKTS:CBIS) released its earnings results on Tuesday, July, 28th. The company reported $0.00 EPS for the quarter.

What other stocks do shareholders of Cannabis Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Science investors own include Medical Marijuana (MJNA), Unrivaled Brands (TRTC), Hemp (HEMP), Aurora Cannabis (ACBFF), Cronos Group (CRON), Aurora Cannabis (ACB), KushCo (KSHB) and Energous (WATT).

What is Cannabis Science's stock symbol?

Cannabis Science trades on the OTCMKTS under the ticker symbol "CBIS."

What is Cannabis Science's stock price today?

One share of CBIS stock can currently be purchased for approximately $0.01.

How can I contact Cannabis Science?

Cannabis Science's mailing address is 19800 Macarthur Blvd Ste 300, IRVINE, CA 92612-2479, United States. The official website for the company is www.cannabisscience.com. The company can be reached via phone at +1-888-8890888.

This page (OTCMKTS:CBIS) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -